174 related articles for article (PubMed ID: 8906746)
1. Complement-dependent binding of C-reactive protein complexes to human erythrocyte CR1.
Mold C; Gurulé C; Otero D; Du Clos TW
Clin Immunol Immunopathol; 1996 Nov; 81(2):153-60. PubMed ID: 8906746
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory potential of C-reactive protein complexes compared to immune complexes.
Romero IR; Morris C; Rodriguez M; Du Clos TW; Mold C
Clin Immunol Immunopathol; 1998 May; 87(2):155-62. PubMed ID: 9614930
[TBL] [Abstract][Full Text] [Related]
3. Immune complex-like moieties in immunoglobulin for intravenous use (i.v.Ig) bind complement and enhance phagocytosis of human erythrocytes.
Shoham-Kessary H; Naot Y; Gershon H
Clin Exp Immunol; 1998 Jul; 113(1):77-84. PubMed ID: 9697987
[TBL] [Abstract][Full Text] [Related]
4. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion.
Tas SW; Klickstein LB; Barbashov SF; Nicholson-Weller A
J Immunol; 1999 Nov; 163(9):5056-63. PubMed ID: 10528211
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of C4Ab and C4Bb binding to the C3b/C4b receptor (CR1, CD35).
Reilly BD; Mold C
Clin Exp Immunol; 1997 Nov; 110(2):310-6. PubMed ID: 9367418
[TBL] [Abstract][Full Text] [Related]
6. The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans.
Schifferli JA; Ng YC; Paccaud JP; Walport MJ
Clin Exp Immunol; 1989 Mar; 75(3):329-35. PubMed ID: 2522842
[TBL] [Abstract][Full Text] [Related]
7. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
Marzocchi-Machado CM; Alves CM; Azzolini AE; Polizello AC; Carvalho IF; Lucisano-Valim YM
J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
[TBL] [Abstract][Full Text] [Related]
8. Complement-opsonized IgG antibody/dsDNA immune complexes bind to CR1 clusters on isolated human erythrocytes.
Taylor RP; Pocanic F; Reist C; Wright EL
Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 1):143-60. PubMed ID: 1833104
[TBL] [Abstract][Full Text] [Related]
9. A study of in vivo immune complex formation and clearance in man.
Davies KA; Hird V; Stewart S; Sivolapenko GB; Jose P; Epenetos AA; Walport MJ
J Immunol; 1990 Jun; 144(12):4613-20. PubMed ID: 2141040
[TBL] [Abstract][Full Text] [Related]
10. Human IgG in immune complexes bound to human erythrocyte CR1 is recognized differently than human IgG bound to an erythrocyte surface antigen.
Reist CJ; Wright JD; Labuguen RH; Taylor RP
J Immunol Methods; 1993 Aug; 163(2):199-208. PubMed ID: 8354889
[TBL] [Abstract][Full Text] [Related]
11. The primate erythrocyte complement receptor (CR1) as a privileged site: binding of immunoglobulin G to erythrocyte CR1 does not target erythrocytes for phagocytosis.
Reinagel ML; Gezen M; Ferguson PJ; Kuhn S; Martin EN; Taylor RP
Blood; 1997 Feb; 89(3):1068-77. PubMed ID: 9028340
[TBL] [Abstract][Full Text] [Related]
12. Binding of immune complexes to erythrocyte CR1 (CD35): difference in requirement of classical pathway components and indication of alternative pathway-mediated binding in C2-deficiency.
Klint C; Gullstrand B; Sturfelt G; Truedsson L
Scand J Immunol; 2000 Jul; 52(1):103-8. PubMed ID: 10886790
[TBL] [Abstract][Full Text] [Related]
13. Binding of Free and Immune Complex-Associated Hepatitis C Virus to Erythrocytes Is Mediated by the Complement System.
Salam KA; Wang RY; Grandinetti T; De Giorgi V; Alter HJ; Allison RD
Hepatology; 2018 Dec; 68(6):2118-2129. PubMed ID: 29742812
[TBL] [Abstract][Full Text] [Related]
14. Exposure to complement-bearing immune complexes enhances the in vitro sequestration of erythrocytes from young but not elderly donors.
Shapiro S; Pilar T; Gershon H
Clin Exp Immunol; 1993 Feb; 91(2):301-7. PubMed ID: 8428395
[TBL] [Abstract][Full Text] [Related]
15. Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1).
Madi N; Paccaud JP; Steiger G; Schifferli JA
Clin Exp Immunol; 1991 Apr; 84(1):9-15. PubMed ID: 1826650
[TBL] [Abstract][Full Text] [Related]
16. The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions.
Lucisano Valim YM; Lachmann PJ
Clin Exp Immunol; 1991 Apr; 84(1):1-8. PubMed ID: 1707767
[TBL] [Abstract][Full Text] [Related]
17. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism.
Craig ML; Bankovich AJ; McElhenny JL; Taylor RP
Arthritis Rheum; 2000 Oct; 43(10):2265-75. PubMed ID: 11037886
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of transfer of immune complexes from red blood cell CR1 to monocytes.
Emlen W; Carl V; Burdick G
Clin Exp Immunol; 1992 Jul; 89(1):8-17. PubMed ID: 1385769
[TBL] [Abstract][Full Text] [Related]
19. Binding to erythrocyte complement receptor type 1 of BSA/anti-BSA complexes opsonized by C4A3 or C4B1 in the presence of serum.
Klint C; Truedsson L; Sturfelt G
Scand J Immunol; 1995 Oct; 42(4):425-32. PubMed ID: 7569775
[TBL] [Abstract][Full Text] [Related]
20. Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions.
Ng YC; Schifferli JA; Walport MJ
Clin Exp Immunol; 1988 Mar; 71(3):481-5. PubMed ID: 2968204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
